Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 72 (RNA5SP72) is a processed pseudogene in the human genome, meaning it is a genetic element that originated from a functional 5S ribosomal RNA gene but has lost its protein-coding ability due to mutations or changes in sequence context[2][4]. Pseudogenes such as RNA5SP72 do not encode functional RNA or protein and are not considered therapeutic targets, receptors, or enzymes[2][4]. They are generally thought to be transcriptionally inactive, though some pseudogenes can have regulatory roles as competitive endogenous RNAs or modulators in gene networks in rare cases[4][6]. RNA5SP72 specifically has no known direct biological function, no role in disease as a protein or RNA product, and is not associated with any targeted drugs or mechanisms of action[2]. Such pseudogenes cannot currently be used as biomarkers or therapeutic targets[2]. There is no indication in the biomedical literature that RNA5SP72 is clinically relevant as a pharmacological or diagnostic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 72 (RNA5SP72).